Sildenafil (Revatio) for Pulmonary Arterial Hypertension
The Medical Letter reported last year that sildenafil (Viagra - Pfizer) appeared to be effective for idiopathic pulmonary arterial hypertension (PAH), but confirmation from a controlled trial was needed. Now the results of such a study are about to be published, and the drug has been approved by the FDA for this indication under the trade name Revatio....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Sildenafil (Revatio) for Pulmonary Arterial Hypertension
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1215
Article Code: 1215a
Date: August 15, 2005
Volume: 47
Pages: 65-67
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1215
Article Code: 1215a
Date: August 15, 2005
Volume: 47
Pages: 65-67
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)